A metabolic disorder that leads to high levels of fat in the blood and life-threatening pancreatic complications now has its first FDA-approved medicine, an RNA-targeting therapy developed by Ionis ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has approved TRYNGOLZA® (olezarsen) as an adjunct to diet ...
CONSTRAINT:: angle_A: 110.6 10.0 50.0 360. 0 CONSTRAINT:: angle_B: 124.0 5.0 50.0 360. 0 CONSTRAINT:: torsion_A: -114.7 10.0 25.0 360. 0 CONSTRAINT:: torsion_AB: 139 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果